Sale of 833 shares at $302.5107 per share.
Reporting Person Reardon Andrew · Officer Title CLO & Secretary · Transaction Code S
Traded Oct 2, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001950232-26-000003 · filed 2026-10-06 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "LIGAND PHARMACEUTICALS INC (LGND)." Disclosed 2026-10-06. https://desqlong.com/cards/0001950232-26-000003-2 (retrieved 2026-10-07).